Lupin LimitedNSE: LUPIN

Press Release May 26 2025

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated May 26, 2025, titled "Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at theAmerican Society of Clinical Oncology - Annual Meeting 2025".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases